Atrás
21
Rango del Día
$322.78
$328.29
Rango de 52 Semanas
$265.59
$377.54
Volumen
1,214,038
Promedio 50D / 200D
$354.06
/
$324.91
Cierre Anterior
$327.27
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 40.7 | 0.2 |
| P/B | 41.9 | 3.0 |
| ROE % | 144.3 | 3.6 |
| Net Margin % | 0.5 | 3.8 |
| Rev Growth 5Y % | 10.7 | 9.9 |
| D/E | 7.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$408.00
+25.5%
Low: $340.00
High: $440.00
P/E Futuro
18.44
EPS Futuro
$17.63
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
345.82B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$27.61
$26.94 – $28.01
|
481.62B | 1 |
| FY2029 |
$24.52
$23.92 – $24.88
|
434.52B | 1 |
| FY2028 |
$21.70
$20.15 – $24.19
|
395.08B | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-04 | $4.05 | $4.08 | +0.7% |
| 2025-11-05 | $3.79 | $3.84 | +1.3% |
| 2025-08-06 | $3.85 | $4.00 | +3.9% |
| 2025-05-07 | $4.11 | $4.42 | +7.5% |
| 2025-02-05 | $3.50 | $3.73 | +6.6% |
| 2024-11-06 | $3.23 | $3.34 | +3.4% |
| 2024-07-31 | $3.22 | $3.34 | +3.7% |
| 2024-05-01 | $3.69 | $3.80 | +3.0% |
Dividend History
7 yr streakYield
0.01%
Payout Ratio
0.28%
Growth (3Y)
6.46%
Growth (5Y)
5.77%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 13, 2026 | Mar 02, 2026 | $0.60 | 0.64% |
| Nov 14, 2025 | Dec 01, 2025 | $0.60 | 0.62% |
| Aug 15, 2025 | Sep 03, 2025 | $0.55 | 0.75% |
| May 16, 2025 | Jun 02, 2025 | $0.55 | 0.74% |
| Feb 14, 2025 | Mar 03, 2025 | $0.55 | 0.87% |
| Nov 15, 2024 | Nov 29, 2024 | $0.55 | 0.87% |
| Aug 09, 2024 | Aug 26, 2024 | $0.51 | 0.86% |
| May 09, 2024 | May 24, 2024 | $0.51 | 0.90% |
| Feb 08, 2024 | Feb 26, 2024 | $0.51 | 0.86% |
| Nov 10, 2023 | Nov 27, 2023 | $0.51 | 0.99% |
| Aug 10, 2023 | Aug 28, 2023 | $0.49 | 1.04% |
| May 11, 2023 | May 30, 2023 | $0.49 | 1.12% |
| Feb 09, 2023 | Feb 27, 2023 | $0.49 | 1.22% |
| Nov 10, 2022 | Nov 28, 2022 | $0.49 | 1.20% |
| Aug 12, 2022 | Aug 29, 2022 | $0.46 | 1.22% |
| May 13, 2022 | May 31, 2022 | $0.46 | 1.19% |
| Feb 11, 2022 | Feb 28, 2022 | $0.46 | 1.28% |
| Nov 12, 2021 | Nov 29, 2021 | $0.46 | 1.42% |
| Aug 13, 2021 | Sep 07, 2021 | $0.44 | 1.47% |
| May 14, 2021 | Jun 01, 2021 | $0.44 | 1.49% |
Puntos Clave
Revenue grew 10.70% annually over 5 years — strong growth
ROE of 144.31% indicates high profitability
Debt/Equity of 7.13 — high leverage
Generating 3.21B in free cash flow
P/E of 40.69 — premium valuation
Cash machine — converts 206.36% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
10.70%
Revenue (1Y)9.31%
Earnings (1Y)2.99%
FCF Growth (3Y)-3.63%
Calidad
Return on Equity
144.31%
ROIC22.32%
Net Margin0.48%
Op. Margin1.14%
Seguridad
Debt / Equity
7.13
Current Ratio0.90
Interest Coverage8.69
Valoración
P/E Ratio
40.69
Forward P/E18.44
P/B Ratio41.93
EV/EBITDA19.08
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9.31% | Revenue Growth (3Y) | 10.71% |
| Earnings Growth (1Y) | 2.99% | Earnings Growth (3Y) | -5.63% |
| Revenue Growth (5Y) | 10.70% | Earnings Growth (5Y) | 0.23% |
| Profitability | |||
| Revenue (TTM) | 321.33B | Net Income (TTM) | 1.55B |
| ROE | 144.31% | ROA | 2.03% |
| Gross Margin | 3.16% | Operating Margin | 1.14% |
| Net Margin | 0.48% | Free Cash Flow (TTM) | 3.21B |
| ROIC | 22.32% | FCF Growth (3Y) | -3.63% |
| Safety | |||
| Debt / Equity | 7.13 | Current Ratio | 0.90 |
| Interest Coverage | 8.69 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.28% |
| Dividend Growth (3Y) | 6.46% | Dividend Growth (5Y) | 5.77% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 40.69 | Forward P/E | 18.44 |
| P/B Ratio | 41.93 | P/S Ratio | 0.20 |
| PEG Ratio | 7.05 | Forward PEG | N/A |
| EV/EBITDA | 19.08 | Fwd EV/EBITDA | 16.04 |
| Forward P/S | 0.18 | Fwd Earnings Yield | 5.42% |
| FCF Yield | 5.07% | ||
| Market Cap | 63.24B | Enterprise Value | 69.59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 321.33B | 293.96B | 262.17B | 238.59B | 213.99B |
| Net Income | 1.55B | 1.51B | 1.75B | 1.70B | 1.54B |
| EPS (Diluted) | 7.96 | 7.53 | 8.53 | 8.04 | 7.39 |
| Gross Profit | 10.14B | 8.70B | 7.76B | 7.60B | 6.27B |
| Operating Income | 3.65B | 3.04B | 2.45B | 2.75B | 2.68B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 76.59B | 67.10B | 62.56B | 56.56B | 57.34B |
| Total Liabilities | 74.84B | 66.31B | 61.89B | 56.49B | 56.75B |
| Shareholders' Equity | 1.51B | 645.94M | 522.00M | -211.56M | 223.35M |
| Total Debt | 10.75B | 6.65B | 6.82B | 7.59B | 8.75B |
| Cash & Equivalents | 4.39B | 3.23B | 2.69B | 3.53B | 2.55B |
| Current Assets | 52.24B | 47.72B | 42.80B | 39.59B | 38.80B |
| Current Liabilities | 57.82B | 54.28B | 48.83B | 43.48B | 41.36B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#444 of 619
Actividad Reciente
Entró
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026